Oxytocin challenges, legal & otherwise

| Updated on August 17, 2018 Published on August 17, 2018

Will the Government push back on its Oxytocin ban on private companies that prevents them from making and marketing the product? Or will it be the Delhi High Court that rules on the issue?

The coming week will see multinational drugmaker Mylan’s writ petition come up at the Delhi HC. The court is likely to hear the plea on August 20. The petition challenges the Government’s ban on private makers of Oxytocin. Also seeking to be heard with them is civil society group All India Drug Action Network that has filed a Public Interest Litigation at the Delhi HC.

Oxytocin treats excessive bleeding in women during childbirth. But its misuse in cattle and poultry to increase milk secretion and production, in addition to concerns of misuse in young girls, triggered the Government’s crackdown. However, doctors caution that restriction on private supplies of Oxytocin could create a shortage, despite one Government company being appointed to make the drug. The coming fortnight could see much legal action in the lead-up to September 1, when the ban is to come into effect.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on August 17, 2018
This article is closed for comments.
Please Email the Editor